BridgeBio Pharma Inc.

05/11/2024 | Press release | Distributed by Public on 05/11/2024 08:39

BBIO – Acoramidis AG10 TTR – ESC Heart Failure 2024 – ITT Sensitivity Analysis and Sub-Analysis Comparing Acoramidis and Placebo in Stage 4 CKD in ATTRibute-CM